71
32
Growth Score
-15 pts
Heat Score
-31 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
730747
Immuthera researches immune-based therapeutics and shares pipeline, publications, and partnering opportunities.
- Dan Shelly: Chief Business Development Officer
About the Company
Immuthera develops immunotherapy research programs and publishes information on experimental medicines targeting immune pathways. The company focuses on discovering drug candidates that modulate immune responses for oncology and inflammatory conditions. Its website highlights pipeline overviews, scientific updates, and opportunities for
collaboration and careers. Immuthera engages with academic and industry partners to translate preclinical findings toward clinical evaluation and provides a contact channel for partnering discussions.
